Skip to main content
# Title Department Research Year
61 COVID-19 associated Mucormycosis among ICU patients: risk factors, control, and challenges 2023
62 Phytoconstituent Isolation and Cytotoxicity Evaluation of the Egyptian Cassia occidentalis L. Possessing Selective Activity against Lung Carcinoma Department of Pharmacognosy 2023
63 Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: Design, synthesis, and biological evaluation Department of Pharmaceutical Organic Chemistry 2023
64 New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity Department of Pharmaceutical Organic Chemistry 2023
65 Ratiometric fluorometric determination of sulfide using graphene quantum dots and self‑assembled thiolate‑capped gold nanoclusters triggered by aluminum Department of Pharmaceutical Analytical Chemistry 2023
66 Chitosan-capped silver nanoparticles with potent and selective intrinsic activity against the breast cancer cells Department of Industrial Pharmacy 2023
67 Phage therapy, a salvage treatment for multidrug-resistant bacteria causing infective endocarditis 2023
68 Thiadiazine-2-thione derivatives as new cell- cycle inhibitors Department of Medicinal Chemistry 2023
69 Phytochemical Investigation, In silico/In vivo Analgesic, and Anti-inflammatory Assessment of the Egyptian Cassia occidentalis L. Department of Pharmacognosy 2023
70 LIPID NANOPARTICLES TECHNOLOGY IN VACCINES; SHAPING THE FUTURE OF PROPHYLACTIC MEDICINE Department of Industrial Pharmacy 2023